Source:Journal of Allergy and Clinical Immunology
Author(s): Nicole Leib, Nadine Herrmann, Susanne Koch, Tim J. Stroisch, Sylvia Schnautz, Helene Wilms, Thomas Bieber
Teaser
miRNA-155 contributes to the inflammatory process in AD by regulating the expression of the high-affinity receptor for IgE (FcεRI) via its transcription factor PU.1. miRNA-155 may represent an interesting new target in AD therapy.http://ift.tt/2vSiPOt
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου